Oral JAK Inhibitors in Atopic Dermatitis
Ruth Ann Vleugels, MD, MPH, MBA, provides an overview of oral JAK inhibitors approved for the treatment of atopic dermatitis and describes what makes them an attractive therapeutic option.
Now Viewing
EP: 1.Oral JAK Inhibitors in Atopic Dermatitis
EP: 2.Oral JAK Inhibitors vs Other Systemic Treatments in Atopic Dermatitis
EP: 3.Candidates for Oral JAK Inhibitor Use in Atopic Dermatitis
EP: 4.Choosing Between Oral JAK Inhibitors in Atopic Dermatitis
EP: 5.Safety Data of Oral JAK Inhibitors in Atopic Dermatitis
EP: 6.Patient Communication and Utilization of JAK Inhibitors in Atopic Dermatitis
Video content above is prompted by the following questions:
- Please review the oral JAK inhibitors that have been approved for atopic dermatitis (AD).
- Which patients are they approved for?
- What makes JAK inhibitors an attractive option for AD treatment?
- How are oral JAK inhibitors utilized in other diseases?
Recent Videos
Related Content
